Parallel Advisors, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$354
-92.9%
11
-96.4%
0.00%
Q4 2021$5,000
-92.4%
308
-86.9%
0.00%
-100.0%
Q3 2021$66,000
+1.5%
2,353
+7.4%
0.00%0.0%
Q2 2021$65,000
+550.0%
2,190
+471.8%
0.00%
+200.0%
Q3 2020$10,000
+11.1%
3830.0%0.00%0.0%
Q2 2020$9,000
+80.0%
3830.0%0.00%
Q1 2020$5,000
-16.7%
3830.0%0.00%
Q4 2019$6,000
+20.0%
3830.0%0.00%
Q3 2019$5,000
+150.0%
383
+150.3%
0.00%
Q2 2019$2,0001530.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders